• roomer_BANERER_01

ʻO Deflazacort kahi anti-inflamortory, anti-allergic, a hoʻonui i nā hopena gluconetogenesis

Kākau pōkole:

Melting point: 255-256.5 ° C

RIPT RATION: D + 62.3 ° (C = 0.5inClorotinform)

Bouling point: 595.4 ± 50.0 ° C (wānanaʻia)

Density: 1.41

Nā Kūlana Kūlana: 2-8 ° C

SUTUBILIT: DMSO: ≥20MGG / ML

Acdidity coible: (pka) 14.30 ± 0.70 (wānanaʻia)

Form: Powder

Kāleka:ʻeleʻele


Huahana kikoʻipiop

Nā Kūlana Huakaʻi

Huahana kikoʻipiop

Inoa Cpllaheanscort
Ka helu helu 14484-47-0
Mlecular noncula Chodreh31no6
Kaupaona molebular 441.52
Nā helu einecs 238-483-7
Makaʻikua 595.4 ± 50.0 ° C
ʻO Menu ka hoʻomaʻemaʻe 98%
Huanui I hoʻopaʻaʻia ma ka maloʻo maloʻo, mahana o ka lumi
ʻAno Pauku
Kāleka Keʻokeʻo
Paliole Nā Pahu + ALUNIIN BRAG

Synonyms

16-D) Oxazole-3,20-dionee, 11-beta, 21-diyactar 11β-hydroxy-21-setiesloxy-1,2,4,5-tetradehydropregn-3,00-dionen; -2'-athylpreggenano [17,16-D] Oxaizole-1,4-Diene-3,20-Dione; 11b, 21-Donazacort

Ka hopena pharmacological

Nā hōʻike
No ka mea nui a iʻole ka hoʻoponoponoʻana i ka adrenal insuffiedy, rheumatism story, nā maʻi maʻi uni-tuberratic

Precations
(1) E like me nā glucocorticicoids'ē aʻe, ua hoʻohālikelikeʻia no nā maʻi maʻi maʻi maʻi.
( ʻO nā wahine hāpai a me nā wahine e hoʻohana ai me ka makaʻala.

Hoʻopiʻi i nā lapaʻau lapaʻau
1. Loaʻa i ka Deflazacort he hopena maikaʻiʻoleʻo Pricassitium
2. I ka wā e hui pū ai me nā lāʻau lapaʻau me nā hana endzymatic
3. Hiki i ka Erythromycin a me Estrogen i ka metabolism o kēia huahana a me nā mea hana ikaika, a pono e hoʻemiʻia nā dosage. Nakiikaikaikaikahana-hexane crystallikation, melting point 255-256.5 ℃. [α] d + 62.3 ° (c = 0.5, chlorotrory).

Hoʻohana
ʻO nā glucocorticictids makahikiʻekolu anti-inflammory, Anti-Allergic, a hoʻonui i nā hopena Gluconeogenesis. No ka hana pilikino a me keʻano o ka adrenal adrenal insuffied, rheomatunis, ka maʻi colutiontitic syndismatity, ka maʻi o nā mea maʻi ametitopotad


  • MAUI:
  • ANE:

  • Kākau i kāu leka uila maʻaneʻi a hoʻouna iā mākou